Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AIM ImmunoTech Inc., 3 years.
AIM ImmunoTech Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AIM ImmunoTech Inc. December 17, 202454.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 14, 2025 | AIM ImmunoTech Inc. | Grant or award | +44,899 | $0.12 | $5,388 |
| Feb 28, 2025 | AIM ImmunoTech Inc. | Grant or award | +38,580 | $0.14 | $5,401 |
| Feb 14, 2025 | AIM ImmunoTech Inc. | Grant or award | +43,330 | $0.12 | $5,200 |
| Jan 31, 2025 | AIM ImmunoTech Inc. | Grant or award | +25,797 | $0.20 | $5,159 |
| Jan 15, 2025 | AIM ImmunoTech Inc. | Grant or award | +27,412 | $0.19 | $5,208 |
| Dec 31, 2024 | AIM ImmunoTech Inc. | Grant or award | +26,305 | $0.20 | $5,261 |
| Dec 13, 2024 | AIM ImmunoTech Inc. | Grant or award | +24,452 | $0.21 | $5,135 |
| Dec 2, 2024 | AIM ImmunoTech Inc. | Grant or award | +22,645 | $0.23 | $5,208 |
| Mar 21, 2024 | AIM ImmunoTech Inc. | Open-market purchase | +38,462 | $0.39 | $15,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.